NovaBay Pharmaceuticals Reports 2015 Second Quarter Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today reported financial results for the three months and six months ended June 30, 2015, and provided a business update. Quarterly and Recent Operational and Financial Highlights Grew sales of Avenova™ Lid and Lash Cleanser by 73% to $806,000 in the second quarter of 2015 ove
